Cancel
Known information
- Received his PhD from the University of East Anglia (UK) where he studied disrupting protein-protein interactions
- Previously worked on targets for oncology and rare diseases
- Works on advancing hit compounds to leads for drug discovery
About Arpeggio Bio
Arpeggio Bio, based in Boulder, CO, specializes in drug discovery targeting transcription factors with AI and RNA-sequencing technologies. The company, with a team of 20, collaborates with industry giants like J&J and FORMA, focusing on diseases such as IO-resistant melanoma and rare genetic disorders.
Report inaccurate information
